RPRX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 1335 min ago

@ $28.54

Wydano: 7 geg. 2024 @ 16:32

Zwrot: -0.91%

Poprzedni sygnał: geg. 6 - 22:12

Poprzedni sygnał: Kupno

Zwrot: 0.30 %

Live Chart Being Loaded With Signals

Commentary (7 geg. 2024 @ 23:00):

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States...

Stats
Dzisiejszy wolumen	2.39M
Średni wolumen	2.83M
Kapitalizacja rynkowa	12.75B
EPS	$0 ( 2024-02-15 )
Następna data zysków	( $0.960 ) 2024-05-09
Last Dividend	$0.200 ( 2023-11-16 )
Next Dividend	$0 ( N/A )
P/E	11.18
ATR14	$0.485 (1.72%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-28	Fernandez Henry A	Buy	1 240	Class A Ordinary Shares
2024-03-28	Bassler Bonnie L	Buy	1 240	Class A Ordinary Shares
2024-02-20	Riggs Rory B	Buy	300 000	Class A Ordinary Shares
2024-02-20	Riggs Rory B	Sell	30 000	LP interests in RPI US Partners 2019, LP
2024-01-02	Riggs Rory B	Sell	235 200	Class A Ordinary Shares

INSIDER POWER
-36.00
Last 100 transactions
Buy: 3 308 362 \| Sell: 7 318 226

Wolumen Korelacja

Długi: 0.94 (very strong)

Krótki: -0.63 (weak negative)

Signal:(58) Neutral

Royalty Pharma plc Korelacja

10 Najbardziej pozytywne korelacje
INCR	0.957
MYSZ	0.939
SPFI	0.937
BMRA	0.933
WATT	0.931
CUTR	0.93
CSSEP	0.925
BWB	0.919
EVLO	0.918
TIVC	0.918

10 Najbardziej negatywne korelacje
ESCA	-0.946
AMTBB	-0.945
BRLI	-0.945
GRIL	-0.944
ARIZ	-0.941
CNGL	-0.94
GBRG	-0.936
LQDA	-0.934
EMLD	-0.934
LMRKO	-0.93

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Royalty Pharma plc Korelacja - Waluta/Towar

0.39
( neutral )

-0.14
( neutral )

0.00
( neutral )

0.73
( moderate )

0.74
( moderate )

Royalty Pharma plc Finanse

Annual	2023
Przychody:	$2.35B
Zysk brutto:	$1.79B (76.19 %)
EPS:	$2.54

FY	2023
Przychody:	$2.35B
Zysk brutto:	$1.79B (76.19 %)
EPS:	$2.54

FY	2022
Przychody:	$2.24B
Zysk brutto:	$2.23B (99.75 %)
EPS:	$0.0978

FY	2021
Przychody:	$2.29B
Zysk brutto:	$0.00 (0.00 %)
EPS:	$0.922

Financial Reports:

No articles found.

Royalty Pharma plc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.190 (N/A)	$0.190 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0.200 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Royalty Pharma plc Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.90 - Increase likely (57.95%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.150	2020-09-14
Last Dividend	$0.200	2023-11-16
Next Dividend	$0	N/A
Payout Date	2023-12-15
Next Payout Date	N/A
# dividends	14	--
Total Paid Out	$2.54	--
Avg. Dividend % Per Year	1.17%	--
Score	4.94	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.90
Div. Directional Score	9.45	--

Next Divdend (Est)
(2024-07-01)

$0.205 Estimate 38.46 %

Dividend Stability

0.77 Good

Dividend Score

4.94

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2020	$0.300	0.67%
2021	$0.680	1.45%
2022	$0.760	1.93%
2023	$0.800	2.03%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Royal	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.482	1.500	0.360	0.540	[0 - 0.5]
returnOnAssetsTTM	0.0693	1.200	7.69	9.23	[0 - 0.3]
returnOnEquityTTM	0.182	1.500	9.09	10.00	[0.1 - 1]
payoutRatioTTM	0.316	-1.000	6.84	-6.84	[0 - 1]
currentRatioTTM	7.90	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.87	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	2.96	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.375	-1.500	3.76	-5.64	[0 - 0.6]
interestCoverageTTM	7.98	1.000	8.15	8.15	[3 - 30]
operatingCashFlowPerShareTTM	6.70	2.00	7.77	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.964	2.00	9.02	10.00	[0 - 20]
debtEquityRatioTTM	0.940	-1.500	6.24	-9.36	[0 - 2.5]
grossProfitMarginTTM	0.697	1.000	1.719	1.719	[0.2 - 0.8]
operatingProfitMarginTTM	0.634	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.488	1.000	8.40	8.40	[0.2 - 2]
assetTurnoverTTM	0.144	0.800	-2.38	-1.900	[0.5 - 2]
Total Score				11.00

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	11.13	1.000	8.98	0	[1 - 100]
returnOnEquityTTM	0.182	2.50	9.41	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.964	2.00	9.35	10.00	[0 - 30]
dividendYielPercentageTTM	2.86	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	6.70	2.00	7.77	10.00	[0 - 30]
payoutRatioTTM	0.316	1.500	6.84	-6.84	[0 - 1]
pegRatioTTM	0.810	1.500	7.93	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	1.271	1.000	10.00	0	[0.1 - 0.5]
Total Score				7.90

Royalty Pharma plc

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

Aktualne aktualizacje dla Royalty Pharma plc [RPRX]

Upcoming Earnings Alert

Royalty Pharma plc Dividend Information - Dividend Knight

Dividend Commentary

Top 10 dividend Companies for NASDAQ

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)